Literature DB >> 7482539

Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.

T M Buetler1, E P Gallagher, C Wang, D L Stahl, J D Hayes, D L Eaton.   

Abstract

Various natural and synthetic compounds are known to protect against cancer by elevating phase II detoxification enzymes. Generally classified as monofunctional, these inducers are believed to trigger cellular signal(s) that activate gene transcription through an antioxidant or electrophile response element (ARE/EpRE) in responsive genes. In contrast, the phase I enzymes of drug metabolism (cytochrome P450s) are not believed to be induced by monofunctional inducers and P450 genes have not been found to contain functional ARE/EpREs. In this study, rats were treated with the monofunctional inducers tert-butylated hydroxyanisole, ethoxyquin, and oltipraz to study the inducibility of individual glutathione S-transferase isozymes, NADP(H):quinone oxidoreductase, gamma-glutamylcysteine synthetase, UDP-glucuronosyl transferase, and cytochrome P450 enzymes. Hepatic mRNAs were analyzed on Northern blots using gene-specific oligonucleotide probes for GST Ya1, Ya2, Yc1, Yc2, Yb1, Yb2, and Yf, for UGT 1*06, and for P450 1A1, 1A2, 2B1, 2C11, 3A2, and 4A1. NADP(H):quinone oxidoreductase and gamma-glutamylcysteine synthetase mRNAs were detected using cDNA probes. All the phase II detoxification enzymes analyzed, except GST Yf, were induced by the three monofunctional inducers, suggesting that these genes may be regulated by a mechanism involving an ARE/EpRE element in their promoter region. Interestingly, it was found that ethoxyquin was a particularly good inducer for both members of the P450 2B family, 2B1 and 2B2, and both ethoxyquin and oltipraz were also capable of modestly inducing P450 1A2 and 3A2. Oltipraz was found to slightly induce P450 2B2, but not 2B1, at the dose and time analyzed. Induction of mRNA generally correlated well with induction of protein levels determined by Western blot and/or enzyme activity measurements for selected enzymes. The results of this study suggest that many phase II enzymes may contain ARE/EpRE elements in addition to those confirmed to be regulated by a mechanism involving ARE/EpRE elements. In addition, it was found that several P450 enzymes were induced by monofunctional inducers, suggesting a possibility that some phase I enzymes may also be regulated by a mechanism involving ARE/EpRE elements.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7482539     DOI: 10.1006/taap.1995.1207

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  26 in total

1.  Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival.

Authors:  Sara B Cullinan; Donna Zhang; Mark Hannink; Edward Arvisais; Randal J Kaufman; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

2.  The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase.

Authors:  Sara B Cullinan; John D Gordan; Jianping Jin; J Wade Harper; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 3.  Formation and signaling actions of electrophilic lipids.

Authors:  Francisco J Schopfer; Chiara Cipollina; Bruce A Freeman
Journal:  Chem Rev       Date:  2011-09-20       Impact factor: 60.622

4.  Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases.

Authors:  C J Henderson; A G Smith; J Ure; K Brown; E J Bacon; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2.

Authors:  David B Buckley; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2009-01-14       Impact factor: 3.922

6.  Transcription regulation of rat glutathione S-transferase Ya subunit gene expression by chemopreventive agents.

Authors:  P Fei; G A Matwyshyn; T H Rushmore; A N Kong
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

7.  PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage.

Authors:  E Bobrovnikova-Marjon; C Grigoriadou; D Pytel; F Zhang; J Ye; C Koumenis; D Cavener; J A Diehl
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

8.  Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver.

Authors:  Neil R Kitteringham; Azman Abdullah; Joanne Walsh; Laura Randle; Rosalind E Jenkins; Rowena Sison; Christopher E P Goldring; Helen Powell; Christopher Sanderson; Samantha Williams; Larry Higgins; Masayuki Yamamoto; John Hayes; B Kevin Park
Journal:  J Proteomics       Date:  2010-04-24       Impact factor: 4.044

9.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.

Authors:  K Itoh; N Wakabayashi; Y Katoh; T Ishii; K Igarashi; J D Engel; M Yamamoto
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

10.  Induced expression of drug metabolizing enzymes by preventive agents: role of the antioxidant response element.

Authors:  Ronald A Lubet; Ruisheng Yao; Clinton J Grubbs; Ming You; Yian Wang
Journal:  Chem Biol Interact       Date:  2009-08-18       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.